Policy makers, industry leaders gather to cement commitment to life sciences industry
Industry and policy makers must continue to work together to support life sciences across Massachusetts, as economic realities and growing global competition challenge growth, said speakers at today's MassBio Policy Leadership Breakfast.
"The Massachusetts Supercluster has attained its stature with a modest amount of planning or strategy. For the most part, we have benefitted from the confluence of world-class teaching hospitals and academic institutions, the talented people those institutions produce, and a robust venture capital community. This position can not be maintained, however, without new approaches in public policy, regulatory efforts and the educational system," said Robert K. Coughlin, President & CEO of MassBio.
The 2015 Report commissioned by MassBio highlighted the number of clusters throughout the world focused on investment in life sciences. Without careful public policy and investment in all stages of a company's life cycle, Massachusetts may jeopardize it's position as a life sciences leader, the report concluded.
"Our industry needs enlightened public policy, municipalities that welcome biotech facilities, collaborative relationships across the local life sciences community, and the best and the brightest candidates to fill jobs ranging from manufacturing technicians to scientists," Coughlin said.
The annual Policy Leadership Breakfast serves to bring leaders from the biotechnology and life sciences industry together with policy makers. Speakers at the 2010 event included Massachusetts Life Sciences Center President Dr. Susan Windham-Bannister, UMass President Jack Wilson, Tufts Medical Center President & CEO Ellen Zane, Richard Pops, Chairman, President & CEO of Alkermes, Mass. Biomedical Initiatives President & CEO Kevin O'Sullivan, and MassBio Board Chairman Mark Leuchtenberger.